Professional Documents
Culture Documents
3 Symposium9 Catheter Related Bloods Treaminfection Full
3 Symposium9 Catheter Related Bloods Treaminfection Full
infection (CR-
(CR-BSI)
1
1.
2.
3.
4.
5.
6.
7
7.
CR-
CR-BSI central venous
catheter
1.3 - 3 1,000 catheter-
catheter-days
PICU
13
13..1%
,
1
1.
, ,
,,
corticosteroid
2.
CR-BSI
1.
2
2.
3.
4
4.
5. transducer (IV tubing)
CR
CR--BSI
Coagulase-
Coagulase-negative staphylococcus aureus
(20
20--50
50%)
%)
Gram negative bacteria Escherichia coli
Pseudomonas aeruginosa (2525%)
%)
Staphylococcus aureus
aureus,, candida (10%)
10%)
-hemolytic
h l i streptococcus
(8.5%))
CR
CR--BSI
Enterococcus
2
-
(9.4%)
-
13 (8.5%)
klebsiella 7.3%
3 coagulase
coagulase--negative
staphylococcus, staphylococcus aureus
CR
CR--BSI
1. Bacteremia fungemia CVC ( (
48
)
)
)
peripheral vein
(
))
(
))
CR
CR--BSI
2.
1 1
> 38 oC,
# , ,
< 1
1
# > 38 oC,
< 37 oC,
3.
CR
CR--BSI
4.
4.1
- semi
semi--quantitative > 15 CFU/catheter
segment
- quantitative
> 103 CFU/catheter
segment
CR
CR--BSI
4.2
peripheral vein
qquantitative blood culture
5 CFU count
peripheral
i h l veini
CR
CR--BSI
4.2
peripheral
i h l vein i
- differential time to positive blood culture
peripheral vein 2
CR
CR--BSI
systemic
(
)
)
MRSA vancomycin
3rd generation cephalosporin aminoglycoside
CR
CR--BSI
(TPN,
, ,
hematologic malignancy)
S.
S aureus
aureus,, candida
candida,, coliform bacteria,
bacteria enterococci
enterococci,,
gram negative bacilli
CR
CR--BSI
CR
CR--BSI
non
non--tunneled
t ld
( day 1 )
)
CR
CR--BSI
(
)
3
CR
CR--BSI
antibiotic--lock therapy (ALT)
antibiotic
(
systemic) ALT
CR
CR--BSI
subclavian,, femoral jugular
subclavian
ultrasound
lumen
CR
CR--BSI
48
Maximal sterile barrier
2% chlorhexidie
( 2 ) )
CR
CR--BSI
dressing
dressing
CR
CR--BSI
CR
CR--BSI
nontunneled guide
wire CR
CR--BSI
CR
CR--BSI
(administration sets)
96 7
(
)
)
24
CR
CR--BSI
Stopcock , ,
72
(access port)
povidone iodine, chlorhexidine
7070%% alcohol
CR
CR--BSI
care bundles
,
, maximal sterile barrier,
CR CR--BSI
systemic